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Increased prevalence of renal cysts in
patients with sickle cell disease
Daveena Meeks1,2, Arunraj Navaratnarajah3, Emma Drasar4, Ounali Jaffer5, C. Jason Wilkins6, Swee Lay Thein7,8
and Claire C. Sharpe9*
Abstract
Background: Early detection and interventions have enabled patients with sickle cell disease (SCD) to live well into
adulthood. Consequently, the chronicity of SCD allows for the insidious manifestation of multisystem complications,
including renal damage. Cystic renal lesions are commonly incidentally discovered on ultrasound and computerised
tomography (CT) imaging of the abdomen. Most are benign simple cysts, however, difficulties may be encountered
if infection, rupture, haemorrhage or cancerous changes develop. We aimed to determine whether patients with
SCD have a higher prevalence of simple renal cysts compared to non-SCD individuals.
Methods: Data for a group of 223 patients with SCD who had undergone an ultrasound and/or CT imaging of the
abdomen were extracted for comparison with 180 control patients (haemoglobin genotype unknown), matched for
age and ethnicity. Scans were evaluated for 198 SCD patients and 180 controls.
Results: Renal cysts were found in 58% of the SCD group and 20% of the controls (OR 5.4 (CI 2.6–11.0), RR 2.8 (CI 1.9–4.2)).
Bilateral renal cysts were found in 28% of the SCD participants in comparison with 5% of the control group. In those who
had one or more cysts identified, the average number of cysts was 3.76 for the SCD group and 1.94 for the controls. Men
with SCD were more likely to develop cysts than women (66% vs 53%), as were men without SCD (22% vs 17%).
Conclusions: Simple renal cysts occur more frequently, are more abundant and develop at a younger age in patients with
SCD than ethnically-matched controls. Further study of the mechanism underlying cyst formation may shed light on both
sickle cell nephropathy and other cystic renal diseases.
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Background
Sickle cell disease (SCD) is one of the most common
inherited blood disorders worldwide [1]. It is caused by
the presence of haemoglobin S (HbS) which results from
the substitution of glutamic acid by valine in the sixth
codon of the beta haemoglobin chain. SCD comprises a
number of genotypes, the most common being homozy-
gous inheritance of two HbS mutations (HbSS). Other
common sickle genotypes include coinheritance of HbS
with another haemoglobin variant, HbC (HbSC), and
beta thalassaemia (and HbSβ+). Patients with HbSS and
HbSβ0 thalassaemia have similar clinical severities and
are often considered as a group termed sickle cell an-
aemia (SCA) [2].
Expansion of newborn screening and early implemen-
tation of comprehensive care has greatly improved
childhood survival in well-resourced countries such that
almost all newborns in these countries can now expect
to survive to adulthood. Improved general medical
management has also helped patients with SCD live
considerably longer, allowing for the insidious manifest-
ation of multisystem complications and end-organ dam-
age [3, 4]. The heavily vascularised renal system is
particularly vulnerable to sickle-related insults leading to
a condition termed sickle cell nephropathy (SCN). Renal
involvement affects approximately 60% of patients with
sickle cell disease (HbSS) at some point during their life
although only 10 to 15% of these patients will develop
end stage renal failure [5].
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The relatively hypoxic and hyperosmolar environment
of the inner medulla promotes polymerization of deoxy-
genated HbS and subsequent sickling of erythrocytes,
resulting in impaired renal medullary blood flow, micro-
infarcts and papillary necrosis. Further to this, the
persistent anaemia and high cardiac output lead to
glomerular hypertrophy and hyperfiltration. Over time
the fine network of vasa recta is destroyed and the swol-
len glomeruli become sclerosed and renal impairment
sets in [5].
Cystic renal lesions are commonly incidentally discov-
ered on ultrasound and computerised tomography (CT)
imaging of the abdomen. Most are benign simple cysts
(Bosniak Classification Stage 1), however, difficulties
may be encountered if infection, rupture, haemorrhage
or cancerous changes develop [6]. King’s College
Hospital (KCH) is a teaching hospital in London that caters
to the healthcare needs of a multi-ethnic community and is
one of the leading Haemoglobinopathy service providers in
the UK. The Haematology and Renal teams at KCH run a
joint SCD/Renal outpatient clinic to care for SCD patients
with kidney dysfunction. The clinical experience encoun-
tered in this clinic has led us to hypothesize that SCD is as-
sociated with a higher prevalence of simple renal cysts [7].
Methods
A cross-sectional study of the ultrasound and compu-
terised tomography (CT) abdominal scans performed on
patients with SCD over a 5 year period was carried out
at KCH. Two hundred twenty three patients aged 16–
59 years, with a clinical diagnosis of sickle cell anaemia
(HbSS or HBSβ0), were identified as having had an ultra-
sound or CT abdominal scan from the Electronic Patient
Records (EPR). We compared the study population
against 180 controls, not known to the sickle cell clinic
at KCH, who were closely matched for age and self-
reported ethnicity (Black or Afro-Caribbean) and who
had presented to Accident & Emergency, within the
same 5 year time frame, and undergone CT imaging of
the abdomen.
Data on the total number of unilateral and bilateral
cysts (> 0.5 cm in diameter) within the kidneys were ex-
tracted from the original verified scan reports on EPR.
Patients with an estimated Glomerular Filtration Rate
(eGFR) of less than 60 ml/min were not included in the
study as both the presence of SCD and renal cysts are
associated with chronic kidney disease. Two independ-
ent radiologists subsequently re-reported all CT scans to
specifically look for renal cysts (>0.5 cm in diameter),
and rendered a consensus opinion if their assessments
differed.
Statistical analyses were performed on 198 SCD partic-
ipants (111 female, 87 male) and 180 controls (53
female, 127 male) and deemed eligible for inclusion in
this study. Associations between SCD and renal cysts
were analysed by logistic regression using IBM SPSS
statistics software. Odds ratios (OR), relative risks (RR)
and 95% confidence intervals (CI) were calculated for
the prevalence for renal cysts amongst the SCD group
compared with the controls. The frequency with which
renal cysts were noted on imaging was assessed using
chi-squared test comparing 2 methods at a time. This
retrospective audit of imaging was not defined as a
research study according to the NHS ‘defining research’
decision tool and therefore in the UK there was no re-
quirement for a submission to be made for ethics com-
mittee approval.
Results
Two hundred twenty three homozygous SCD patients
were identified as having had an ultrasound or CT
abdominal scan. Twenty five patients were ineligible for
inclusion in this study, 24 had an eGFR <60 ml/min and
one had no eGFR data. One hundred ninety eight SCD
patients met the inclusion criteria, of which 43 had
undergone CT abdominal scans and 155 had undergone
ultrasonography. These data were compared against the
CT abdominal scans of 180 controls (Tables 1 and 2).
Re-reports of CT scans, confirmed renal cysts in 58%
of the SCD group and 20% of the controls (OR 5.4 (CI
2.6–11.0), RR 2.8 (CI 1.9–4.2)). Bilateral renal cysts were
found in 28% of the SCD participants in comparison
with 5% of the control group. Although men with SCD
were more likely to have renal cysts than women (66%
vs 53%) this difference was not statistically significant.
Similarly, in the control group, 22% of men vs 17% of
women had cysts but this was also not significant. On
average, the number of cysts identified (in those who
had cysts) was 3.76 for the SCD group and 1.94 for the
control group. The prevalence of renal cysts increased
with age amongst the SCD group, and to a lesser extent
in the control group (Fig. 1). Original CT reports men-
tioned the presence of renal cysts in patients with SCD
2-fold more frequently than did ultrasound reports
(p < 0.05). Re-reporting of CT scans to look specifically
for cysts confirmed their presence in 2.8 fold more
Table 1 Age and gender distribution of the SCD cohort and
control patients
Age SCD Controls
<20 40 (36% M) 47 (85% M)
20–29 67 (44% M) 46 (76% M)
30–39 52 (27% M) 31 (61% M)
40–49 26 (23% M) 46 (54% M)
50–59 13 (54% M) 10 (80% M)
Total 198 (44% M) 180 (71% M)
M Male
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patients than had been suggested from the original
reports (p < 0.05) (Fig. 2).
Discussion
In this study, confirmed renal cysts were present in more
than half of the SCD group (58%) compared to only a
fifth of controls. In addition, in those patients who had
one or more renal cysts, SCD patients had higher
numbers compared to those found in the control group.
Previous studies on the prevalence of simple renal cysts
on CT imaging have demonstrated that they are more
frequently detected with increasing age and that they are
more prevalent in men, and our results are in keeping
with this [8, 9] (Fig. 1). Carrim et al. studied images from
617 patients, though they were significantly older than
our study groups (average age for women 62.8 years and
65.5 for men) with only 49 patients (8%) being below the
age of 40 and 216 (35%) below 60. It is worth noting that
only 8% of those under the age of 40 had detectable
renal cysts and 75% of these were female, though the
numbers were small. In the 40–60 age group, 27.5% had
renal cysts (60% male) and overall, 23% of those under
the age of 60 had renal cysts, 58% of whom were male.
The prevalence of renal cysts in the under 60 age group
was therefore similar to that found in our control
population (23% vs 20%). Although our control group
had a greater proportion of men than the SCD group
(71% vs 44%), the prevalence of cysts in the SCD overall
remained significantly higher across all age groups.
We found that incidental simple renal cysts were re-
ported about two-fold more frequently on the original
radiologists’ CT abdominal scans compared with the
ultrasonography reports. Re-reporting of the CT scans
identified nearly three times the number of cysts initially
reported (Fig. 2). Ultrasound scans are significantly less
sensitive at detecting small renal cysts and the stored
images may not be representative of the kidneys as-a-
whole, making re-reporting of ultrasound scans unreli-
able. However, this highlights the issue that renal cysts
are routinely under-recognised and under-reported in
the clinical setting.
The physiologically hypoxic, hyperosmolar nature of
the medulla prompts sickling of dehydrated haemoglo-
bin and vascular occlusion [5, 10]. The toxic release of
free heme within the kidney leads to nitric oxide
depletion and regional variation in the partial pressure
of oxygen in the kidney [11, 12]. Over time, recurrent
vaso-occlusion may cause microthrombosis, vasculopa-
thy, and glomerular and tubular ischaemia, leading to
SCN, chronic kidney disease (CKD) and end-stage
kidney disease (ESKD) [5, 10, 11, 13–15].
Multiple bilateral renal cysts are characteristic of poly-
cystic kidney disease (PKD), and its pathology has been
linked to over-activation of Hypoxia-inducible factor
1-alpha (HIF-1α) in the epithelial layer and Hypoxia-
inducible factor 2-alpha (HIF-2α) in the cystic wall [16].
Renal impairment secondary to PKD has also been
shown to be accelerated in patients who are heterozy-
gous for the HbS gene (sickle cell trait) [17].
There is increasing empirical data indicating the role
of Hypoxia-inducible factors (HIF) in the pathogenesis
of renal cysts. Hypoxia-inducible factors-1 and -2 (HIF-1
and HIF-2) are heterodimer regulators of oxygen
homeostasis, thought to control glycolysis and erythro-
poietin, respectively. HIFα- and β-subunits sense oxygen
deficits and mediate compensatory genetic transcription.
Table 2 Prevalence of Renal Cysts in sickle cell disease group (SCD) group versus ethnically-matched controls
SCD (% of cohort) Control group (% of cohort) Odds ratio (95% CI) Relative Risk (95%CI)
>1 renal cyst (no. with bilateral cysts) 58% 20% 5.4 (2.6–11.0) 2.8 (1.9–4.2)




Fig. 1 Prevalence of one or more renal cysts in patients with sickle cell disease (SCD) versus controls stratified by age using re-reported CT imaging
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Under low oxygen tension or inflammation (both of
which are present in the kidney in SCD) HIF-α is
activated and combines with the β-subunit (HIF-β) to
upregulate cellular adaptation. In the kidney, HIF-1α is
widely expressed, whereas HIF-2α is predominately con-
fined to the interstitial fibroblasts and endothelium.
HIF-1α is expressed in the nuclei of the tubular epithe-
lium despite hypoxia; HIF-2α, however, is not expressed
here [18]. Hydrolysis of HIF-α is suppressed during tran-
sient hypoperfusion. Short-term activation of HIF is a
prerequisite to tissue survival during transient hypoper-
fusion. Paradoxically, chronic stimulation may cause
renal parenchymal connective tissue deposition and
CKD [18, 19]. Additionally, a propensity for abnormal
HIF-1α activation under normal oxygen tension, amplifi-
cation of HIF-1α expression under low oxygen tension
and the presence of renal cysts has also been demon-
strated in SCD mouse models [20, 21].
The α-subunit (HIF-α) undergoes proteolysis during
normoxia by the Von Hippel-Lindau (VHL) tumour
suppressor [18] and patients with Von Hippel-Lindau
disease (an autosomal dominant syndrome that occurs
secondary to germline mutations in the VHL tumour
suppressor gene) develop multiple simple renal cysts at a
young age and renal cell carcinoma later in life [18, 22].
Double-knockout mouse models for both VHL/HIF-1α
and VHL/HIF-2α however do not develop kidney cysts,
indicating the importance of both proteins for cyst for-
mation [23].
The strengths of this study lie in the novel identifica-
tion of cystic renal lesions in patients with SCD when
compared to an age and ethnically matched control
group. The limitations arise from analysis of point of
care imaging, so not all patients had the gold standard
of cross-sectional imaging. The retrospective nature of
work meant that we were not able to determine whether
the participants were symptomatic or had developed
cyst-related complications. We acknowledge that the in-
creased prevalence of renal cysts in patients with SCD
does not necessarily imply cause and effect. Although
the control group had a greater proportion of men than
the SCD group, our data is in keeping with that ob-
served in previous studies demonstrating a small pre-
ponderance for men to develop renal cysts over women,
which does not appear to be further impacted on by the
presence of SCD.
Conclusion
Further study of the VHL/HIFα pathway may help us to
develop new treatments for progressive cystic diseases of
the kidney. In addition it may help us to understand
their significance in patients with SCD, as extensive use
of medical imaging will continue to highlight their in-
creased prevalence in these patients.
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